Free Trial

Dynamic Technology Lab Private Ltd Invests $891,000 in Chemed Corporation $CHE

Chemed logo with Medical background

Key Points

  • Dynamic Technology Lab Private Ltd made a new investment of approximately $891,000 in Chemed Corporation, acquiring 1,448 shares in the first quarter.
  • Chemed reported a quarterly EPS of $4.27, falling short of the consensus estimate of $6.02, with a revenue of $618.80 million, below expectations of $650.60 million.
  • The company recently increased its quarterly dividend to $0.60, reflecting a positive change from the previous $0.50 dividend, with a current yield of 0.5% and a payout ratio of 12.34%.
  • Five stocks we like better than Chemed.

Dynamic Technology Lab Private Ltd bought a new stake in Chemed Corporation (NYSE:CHE - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 1,448 shares of the company's stock, valued at approximately $891,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Whipplewood Advisors LLC grew its stake in shares of Chemed by 54.5% in the 1st quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock valued at $31,000 after purchasing an additional 18 shares during the last quarter. Renasant Bank grew its stake in shares of Chemed by 2.3% in the 1st quarter. Renasant Bank now owns 815 shares of the company's stock valued at $501,000 after purchasing an additional 18 shares during the last quarter. Impact Capital Partners LLC grew its stake in shares of Chemed by 2.7% in the 1st quarter. Impact Capital Partners LLC now owns 763 shares of the company's stock valued at $469,000 after purchasing an additional 20 shares during the last quarter. KFG Wealth Management LLC grew its stake in shares of Chemed by 4.6% in the 1st quarter. KFG Wealth Management LLC now owns 525 shares of the company's stock valued at $323,000 after purchasing an additional 23 shares during the last quarter. Finally, First Horizon Advisors Inc. lifted its holdings in shares of Chemed by 16.1% in the 1st quarter. First Horizon Advisors Inc. now owns 173 shares of the company's stock valued at $107,000 after buying an additional 24 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Patrick P. Grace sold 150 shares of Chemed stock in a transaction on Tuesday, September 9th. The stock was sold at an average price of $463.39, for a total transaction of $69,508.50. Following the completion of the transaction, the director directly owned 3,397 shares of the company's stock, valued at approximately $1,574,135.83. The trade was a 4.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Nicholas Michael Westfall sold 10,012 shares of the business's stock in a transaction on Monday, August 4th. The stock was sold at an average price of $421.91, for a total value of $4,224,162.92. The disclosure for this sale can be found here. 3.29% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

CHE has been the subject of several recent analyst reports. Wall Street Zen cut Chemed from a "buy" rating to a "hold" rating in a report on Saturday, July 5th. Royal Bank Of Canada reduced their price target on Chemed from $640.00 to $589.00 and set an "outperform" rating for the company in a report on Thursday, July 31st. Oppenheimer reduced their price target on Chemed from $650.00 to $580.00 and set an "outperform" rating for the company in a report on Thursday, July 31st. Bank of America reduced their price target on Chemed from $610.00 to $595.00 and set a "buy" rating for the company in a report on Wednesday. Finally, Jefferies Financial Group raised Chemed from a "hold" rating to a "buy" rating and raised their price target for the company from $490.00 to $550.00 in a report on Tuesday, September 2nd. Four research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $578.50.

Check Out Our Latest Research Report on Chemed

Chemed Stock Performance

CHE stock traded down $11.89 during midday trading on Friday, hitting $446.00. 160,245 shares of the stock were exchanged, compared to its average volume of 167,051. The stock's 50-day moving average price is $451.83 and its 200-day moving average price is $530.54. The stock has a market cap of $6.50 billion, a price-to-earnings ratio of 22.93, a PEG ratio of 2.60 and a beta of 0.46. Chemed Corporation has a fifty-two week low of $408.42 and a fifty-two week high of $623.60.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $4.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.02 by ($1.75). The firm had revenue of $618.80 million for the quarter, compared to analyst estimates of $650.60 million. Chemed had a return on equity of 25.83% and a net margin of 11.56%.The business's revenue for the quarter was up 3.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.47 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Research analysts anticipate that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Monday, August 11th were issued a dividend of $0.60 per share. This is a boost from Chemed's previous quarterly dividend of $0.50. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend was Monday, August 11th. Chemed's payout ratio is presently 12.34%.

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Articles

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.